Edition:
United States

Hutchison China MediTech Ltd (HCM.L)

HCM.L on London Stock Exchange

4,550.00GBp
12:11pm EDT
Change (% chg)

-100.00 (-2.15%)
Prev Close
4,650.00
Open
4,650.00
Day's High
--
Day's Low
--
Volume
7,601
Avg. Vol
13,232
52-wk High
5,668.00
52-wk Low
3,180.00

About

Hutchison China MediTech Limited (Chi-Med) is a China-based, globally-focused healthcare group. The Company researches, develops, manufactures and sells pharmaceuticals and health-related consumer products. Its Innovation Platform focuses on discovering and developing therapeutics in oncology and autoimmune diseases for the... (more)

Overall

Beta: 1.88
Market Cap(Mil.): £3,114.18
Shares Outstanding(Mil.): 66.66
Dividend: --
Yield (%): --

Financials

  HCM.L Industry Sector
P/E (TTM): -- 62.58 62.94
EPS (TTM): -0.87 -- --
ROI: -15.96 12.13 11.75
ROE: -17.59 13.07 12.58

Biotech group Chi-Med plans Hong Kong listing of up to $500 million: sources

HONG KONG Biotech company Hutchison China MediTech, known as Chi-Med, has filed for a Hong Kong listing, which four sources close to the matter said could raise up to $500 million.

Apr 15 2019

Biotech group Chi-Med plans Hong Kong listing of up to $500 mln - sources

HONG KONG, April 15 Biotech company Hutchison China MediTech, known as Chi-Med, has filed for a Hong Kong listing, which four sources close to the matter said could raise up to $500 million.

Apr 15 2019

Earnings vs. Estimates